Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Agilon Health (AGL) EBT (2020 - 2025)

Agilon Health's EBT history spans 6 years, with the latest figure at -$187.6 million for Q4 2025.

  • For Q4 2025, EBT fell 79.18% year-over-year to -$187.6 million; the TTM value through Dec 2025 reached -$404.1 million, down 62.4%, while the annual FY2025 figure was -$404.1 million, 62.4% down from the prior year.
  • EBT reached -$187.6 million in Q4 2025 per AGL's latest filing, down from -$110.5 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $8.2 million in Q1 2023 to a low of -$296.9 million in Q2 2021.
  • Average EBT over 5 years is -$66.1 million, with a median of -$32.9 million recorded in 2021.
  • Peak YoY movement for EBT: plummeted 8616.79% in 2021, then surged 1150.69% in 2023.
  • A 5-year view of EBT shows it stood at -$35.6 million in 2021, then fell by 14.87% to -$40.9 million in 2022, then plummeted by 307.77% to -$166.9 million in 2023, then surged by 37.27% to -$104.7 million in 2024, then tumbled by 79.18% to -$187.6 million in 2025.
  • Per Business Quant, the three most recent readings for AGL's EBT are -$187.6 million (Q4 2025), -$110.5 million (Q3 2025), and -$104.3 million (Q2 2025).